Effects Of Gong's Versus Mulligan Mobilization In Patients With Adhesive Capsulitis
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 12, 2024
Trial Information
Current as of August 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different treatment techniques for patients who have a condition called adhesive capsulitis, commonly known as frozen shoulder. In this condition, the shoulder becomes stiff and painful, making it hard to move. The trial will compare the effects of two types of physical therapy, Gong's mobilization and Mulligan mobilization, to see which one helps patients feel better and regain their shoulder movement more effectively.
To participate in this study, you should be between 40 and 50 years old, and have already been diagnosed with a frozen shoulder that is in the "frozen phase." If you have had recent shoulder surgery, fractures, or certain other conditions, you may not be eligible. If you qualify and decide to join, you will be randomly placed into one of the two treatment groups. Throughout the trial, healthcare professionals will monitor your progress and evaluate how the treatments affect your shoulder. This study aims to help improve treatment options for individuals suffering from this painful condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 40 to 50 years
- • Both male and female
- • Pre-diagnosed Unilateral Primary Frozen shoulder patients
- • Prediagnosed Stage 3(Frozen phase) patients(27)
- Exclusion Criteria:
- • Patients with previous surgery in the shoulder joint
- • History of recent fracture or severe trauma to the shoulder
- • Diagnosed instability or previous history of dislocation
- • Systemic inflammatory conditions(e.g.rheumatoid arthritis)
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Muhammad Hassan, MSPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported